On August 18, 2015, the FDA issued a MedWatch alert alerting healthcare professionals not to administer compounded or repackaged drugs to patients that have been stored in Becton-Dickinson (BD) 3 mL and 5 mL Syringes, unless there is no suitable alternative available.
Join us as a member
Filled out our membership form and join CARS Membership today for more radiopharmaceutical and scientific knowledge.